Effectiveness of β-blockers in heart failure with left ventricular systolic dysfunction and chronic kidney disease

Journal of Cardiac Failure

Volumn 19, Issue 3, 2013, Pages 176-182

  Chang, Tara I ^a   Yang, Jingrong ^b   Freeman, James V ^a   Hlatky, Mark A ^a   Go, Alan S ^a,b,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DIVISION OF RESEARCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

beta blockers; cardiovascular disease; chronic kidney disease; death; epidemiology; Heart failure; hospitalizations; renal dysfunction

Indexed keywords

ACEBUTOLOL; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; NADOLOL; NEBIVOLOL; PENBUTOLOL; PINDOLOL; PROPRANOLOL; SOTALOL; TIMOLOL;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEINURIA; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84875170221     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2013.01.006     Document Type: Article

References (36)

1. Writing Committee Members S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, and T.G. Ganiats 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
2. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, and T.G. Ganiats ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society Circulation 112 2005 1825 1852
3. J.T. Heywood, G.C. Fonarow, M.R. Costanzo, V.S. Mathur, J.R. Wigneswaran, and J. Wynne High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database J Card Fail 13 2007 422 430
4. F.A. McAlister, J. Ezekowitz, M. Tonelli, and P.W. Armstrong Renal Insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study Circulation 109 2004 1004 1009
5. G.L. Smith, J.H. Lichtman, M.B. Bracken, M.G. Shlipak, C.O. Phillips, and P. DiCapua Renal impairment and outcomes in heart failure: systematic review and meta-analysis J Am Coll Cardiol 47 2006 1987 1996
6. D.L. Dries, D.V. Exner, M.J. Domanski, B. Greenberg, and L.W. Stevenson The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction J Am Coll Cardiol 35 2000 681 689
7. I.S. Anand, K. Bishu, T.S. Rector, A. Ishani, M.A. Kuskowski, and J.N. Cohn Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure Circulation 120 2009 1577 1584
8. M.G. Shlipak, G.L. Smith, S.S. Rathore, B.M. Massie, and H.M. Krumholz Renal function, digoxin therapy, and heart failure outcomes: evidence from the Digoxin Intervention Group trial J Am Soc Nephrol 15 2004 2195 2203
9. CIBIS-II Investigators and Committees The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
10. A. Hjalmarson, S. Goldstein, B. Fagerberg, H. Wedel, F. Waagstein, and J. Kjekshus Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF) JAMA 283 2000 1295 1302
11. M. Packer, M.R. Bristow, J.N. Cohn, W.S. Colucci, M.B. Fowler, E.M. Gilbert US Carvedilol Heart Failure Study Group The effect of carvedilol on morbidity and mortality in patients with chronic heart failure N Engl J Med 334 1996 1349 1355
12. M. Packer, A.J. Coats, M.B. Fowler, H.A. Katus, H. Krum, and P. Mohacsi Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 2001 1651 1658
13. D.J. van Veldhuisen, A. Cohen-Solal, M. Bohm, S.D. Anker, D. Babalis, and M. Roughton Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: data from SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure) J Am Coll Cardiol 53 2009 2150 2158
14. A. Cohen-Solal, D. Kotecha, D.J. van Veldhuisen, D. Babalis, M. Bohm, and A.J. Coats Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial Eur J Heart Fail 11 2009 872 880
15. E. Erdmann, P. Lechat, P. Verkenne, and H. Wiemann Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure Eur J Heart Fail 3 2001 469 479
16. J.K. Ghali, J. Wikstrand, D.J. van Veldhuisen, B. Fagerberg, S. Goldstein, and A. Hjalmarson The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF) J Card Fail 15 2009 310 318
17. W.A. Ray Evaluating medication effects outside of clinical trials: new-user designs Am J Epidemiol 158 2003 915 920
18. J.T. Heywood, G.C. Fonarow, C.W. Yancy, N.M. Albert, A.B. Curtis, and W.G. Stough Influence of renal function on the use of guideline-recommended therapies for patients with heart failure Am J Cardiol 105 2010 1140 1146
19. J. Ezekowitz, F.A. McAlister, K.H. Humphries, C.M. Norris, M. Tonelli, and W.A. Ghali The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease J Am Coll Cardiol 44 2004 1587 1592
20. N. Krieger Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology Am J Public Health 82 1992 703 710
21. A.S. Go, W.Y. Lee, J. Yang, J.C. Lo, and J.H. Gurwitz Statin therapy and risks for death and hospitalization in chronic heart failure JAMA 296 2006 2105 2111
22. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
23. R.W. Yeh, S. Sidney, M. Chandra, M. Sorel, J.V. Selby, and A.S. Go Population trends in the incidence and outcomes of acute myocardial infarction N Engl J Med 362 2010 2155 2165
24. A.S. Go, J. Yang, J.H. Gurwitz, J. Hsu, K. Lane, and R. Platt Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice Arch Intern Med 168 2008 2415 2421
25. A.S. Go, J. Yang, L.M. Ackerson, K. Lepper, S. Robbins, and B.M. Massie Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) study Circulation 113 2006 2713 2723
26. E.S. Johnson, B.A. Bartman, B.A. Briesacher, N.S. Fleming, T. Gerhard, and C.J. Kornegay The incident user design in comparative effectiveness research Pharmacoepidemiol Drug Saf 22 2013 1 6
27. G.L. Myers, W.G. Miller, J. Coresh, J. Fleming, N. Greenberg, and T. Greene Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program Clin Chem 52 2006 5 18
28. A.S. Levey, L.A. Stevens, C.H. Schmid, Y.L. Zhang, A.F. Castro 3rd, and Feldman H.I. A new equation to estimate glomerular filtration rate Ann Intern Med 150 2009 604 612
29. T.B. Newman, and A.N. Brown Use of commercial record linkage software and vital statistics to identify patient deaths J Am Med Inform Assoc 4 1997 233 237
30. M.G. Arellano, G.R. Petersen, D.B. Petitti, and R.E. Smith The California Automated Mortality Linkage System (CAMLIS) Am J Public Health 74 1984 1324 1330
31. J.V. Selby, G.T. Ray, D. Zhang, and C.J. Colby Excess costs of medical care for patients with diabetes in a managed care population Diabetes Care 20 1997 1396 1402
32. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
33. A.S. Levey, J. Coresh, T. Greene, L.A. Stevens, Y.L. Zhang, and S. Hendriksen Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate Ann Intern Med 145 2006 247 254
34. A.S. Levey, J. Coresh, K. Balk, A.T. Kausz, A. Levin, and M.W. Steffes National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification Annals Internal Med 139 2002 137 147
35. B.H. Fireman, L. Fehrenbacher, E.P. Gruskin, and G.T. Ray Cost of care for patients in cancer clinical trials J Natl Cancer Inst 92 2000 136 142
36. R.K. Wali, M. Iyengar, G.J. Beck, D.M. Chartyan, M. Chonchol, and M.A. Lukas Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials Circ Heart Fail 4 2011 18 26